En esta página
01JBIO precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
13Dividendos
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
JBIO Jade Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$14,12
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$8,36mínimo 52 semanas
$28,00máximo 52 semanas
Capitalización Bursátil (MRQ)
$897M
P/E
-4.4
BPA
$-3.19
tus insignias
Rango 52S
$8–$28
Calificación del Analista
STRONG BUY
Precio Objetivo
$50
P/E
-4.4
ROE
-47.7%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
JBIO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$14.12
Capitalización Bursátil (MRQ)
$897M
P/E
-4.4
BPA
$-3.19
ROE
-47.7%
Rango 52S
$8–$28
JBIO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 29 de abril de 2025 | 1-for-35 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-3.192021-12-31 → 2025-12-31
Flujo de caja libre$-95M2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | JBIO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -4.4promedio 5A ≈-205.6 | ≈-205.6 | · | · | |
| P/C (MRQ) | 2.0promedio 5A ≈99.4 | ≈99.4 | 3.9 | Infravalorado | |
| Price / FCF (Precio / FCF) | -7.3promedio 5A ≈-351.1 | ≈-351.1 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -7.4promedio 5A ≈-289.8 | ≈-289.8 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 2.1promedio 5A ≈115.4 | ≈115.4 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | JBIO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -60.3%promedio 5A ≈-48.7% | ≈-48.7% | -39.1% | Débil | |
| ROE | -47.7%promedio 5A ≈-79.5% | ≈-79.5% | -45.9% | En línea | |
| ROIC | -34.2%promedio 5A ≈-52.3% | ≈-52.3% | -59.1% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | JBIO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 14.9promedio 5A ≈26.9 | ≈26.9 | 7.0 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 20.3promedio 5A ≈26.0 | ≈26.0 | 1.5 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
| Fecha ex-dividendo | Monto | Moneda | Rendimiento |
|---|---|---|---|
| Abr 29, 2025 | $2,40 | USD | ≈23.7% |
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-9.4%
Próximo informe
Nov 11, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 11, 2026 | $-0.76 | $-0.65 | -17.2% |
| 31 de marzo de 2026 | $-0.57 | $-0.49 | -15.8% | |
| 31 de diciembre de 2025 | $-0.59 | $-0.48 | -22.0% | |
| 30 de septiembre de 2025 | $-0.48 | $-0.69 | 30.2% | |
| 30 de junio de 2025 | $-0.86 | $-0.44 | -94.8% | |
| 31 de marzo de 2025 | $-3.15 | $-8.57 | 63.2% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $93M | $53M | $64M | $39M | $15M | $8M | |
| SG&A Expense | $20M | $21M | $17M | $15M | $8M | $949.0K | |
| Operating Expenses | $114M | $75M | $81M | $53M | $23M | $9M | |
| Operating Income | $-114M | $-75M | $-81M | $-53M | $-23M | $-9M | |
| Interest Expense | · | · | · | · | · | $75.0K | |
| Other Non-op | $-8.0K | $-19.0K | $-1.0K | $2M | $62.0K | $-722.0K | |
| Pretax Income | $-127M | $-70M | $-75M | $-51M | $-23M | $-10M | |
| Income Tax | $58.0K | $55.0K | $56.0K | $25.0K | $3.0K | · | |
| Net Income | $-127M | $-70M | $-76M | $-52M | $-23M | $-10M | |
| EPS (Basic) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · | |
| EPS (Diluted) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · | |
| Shares (Basic) | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · | |
| Shares (Diluted) | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · | |
| EBITDA | $-114M | $-75M | $-81M | $-53M | $-23M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $69M | $23M | $22M | $54M | $5M | |
| Short-term Investments | $248M | $0 | $99M | $107M | $113M | · | |
| Prepaid Expense | $13M | $268.0K | $2M | $2M | $7M | $103.0K | |
| Current Assets | $349M | $70M | $124M | $131M | $174M | $5M | |
| PP&E (Net) | $170.0K | · | $288.0K | $242.0K | $186.0K | $39.0K | |
| PP&E (Gross) | · | · | · | · | · | $40.0K | |
| Accum. Depreciation | · | · | · | · | · | $1.0K | |
| Other Non-current Assets | $69.0K | $3M | $2M | $3M | $302.0K | · | |
| Total Assets | $350M | $73M | $127M | $135M | $175M | $5M | |
| Accounts Payable | $2M | $1M | $2M | $3M | $1M | $618.0K | |
| Accrued Liabilities | $9M | $4M | · | · | · | · | |
| Current Liabilities | $17M | $12M | $18M | $8M | $3M | $2M | |
| Capital Leases | $724.0K | $0 | $255.0K | $705.0K | $382.0K | · | |
| Total Liabilities | $17M | $120M | $18M | $9M | $3M | $2M | |
| Common Stock | $5.0K | $1.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $507M | $179.0K | $273M | $215M | $209M | $63.0K | |
| Retained Earnings | $-174M | $-47M | $-163M | $-88M | $-36M | $-13M | |
| AOCI | $129.0K | $0 | $237.0K | $-466.0K | $-59.0K | · | |
| Stockholders' Equity | $333M | $-47M | $109M | $127M | $172M | $-13M | |
| Liabilities + Equity | $350M | $73M | $127M | $135M | $175M | $5M | |
| Shares Outstanding | 49,316,287 | 3,672,794 | 27,762,703 | 24,722,974 | 24,410,393 | 243,076 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $20M | $11M | $12M | $5M | $2M | $58.0K | |
| Deferred Tax | $-44.0K | · | · | · | · | · | |
| Operating Cash Flow | $-95M | $-71M | $-57M | $-39M | $-27M | $-8M | |
| CapEx | $196.0K | · | $142.0K | $195.0K | $181.0K | · | |
| Investing Cash Flow | $-247M | $56M | $12M | $7M | $-113M | · | |
| Stock Issued | · | $24M | $45M | · | $127M | · | |
| Net Stock Activity | · | $24M | $45M | · | $127M | · | |
| Financing Cash Flow | $361M | $25M | $46M | $396.0K | $190M | $9M | |
| Net Change in Cash | $19M | $10M | $1M | $-32M | $50M | $1M | |
| Free Cash Flow | $-95M | · | $-57M | $-39M | $-28M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -60.3% | -67.0% | -57.5% | -33.2% | -25.5% | · | |
| ROE | -47.7% | -233.8% | -64.2% | -38.8% | -13.0% | · | |
| ROIC | -34.2% | -97.7% | -74.4% | -42.0% | -13.4% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.1 | 20.9 | 7.0 | 16.9 | 68.4 | · | |
| Quick Ratio | 20.3 | 20.5 | 6.9 | 16.6 | 65.6 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.74 | $2.64 | $3.94 | $5.13 | $7.06 | · | |
| Cash Flow / Share | $-3.02 | $-2.49 | $-2.16 | $-1.60 | · | · | |
| Cash / Share | $1.79 | $1.16 | $0.85 | $0.91 | $2.22 | · | |
| EPS (TTM) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-127M | $-70M | $-76M | $-52M | $-23M | · | |
| Market Cap | $761M | $2.69B | $21.99B | $25.35B | $10.07B | · | |
| P/E | -4.8 | -38.0 | -276.0 | -488.3 | -220.7 | · | |
| P/B | 2.3 | 35.2 | 200.9 | 200.0 | 58.4 | · | |
| P / Tangible Book | 2.3 | · | 200.9 | 200.0 | 58.4 | · | |
| P / Cash Flow | -8.0 | -37.8 | -387.3 | -648.1 | -367.6 | · | |
| P / FCF | -8.0 | · | -386.3 | -644.8 | -365.2 | · | |
| Earnings Yield | -20.7% | -2.6% | -0.36% | -0.20% | -0.45% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $50M | $36M | $29M | $22M | $23M | $20M | $-2M | $14M | $21M | $20M | $18M | $17M | $16M | $13M | $12M | $11M | |
| SG&A Expense | $9M | $7M | $6M | $5M | $5M | $3M | $11M | $1M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $59M | $43M | $55M | $27M | $28M | $23M | $9M | $15M | $26M | $25M | $22M | $21M | $20M | $18M | $16M | $14M | |
| Operating Income | $-59M | $-43M | $-55M | $-27M | $-28M | $-23M | $-9M | $-15M | $-26M | $-25M | $-22M | $-21M | $-20M | $-18M | $-16M | $-14M | |
| Other Non-op | $-62.0K | $-9.0K | $4M | $-28.0K | $0 | $0 | $-1M | $0 | $1M | $-3.0K | $-2M | $1.0K | $1M | $1M | $2M | $4.0K | |
| Pretax Income | $-56M | $-40M | · | · | $-32M | $-38M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $15.0K | $16.0K | $58.0K | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-56M | $-40M | $-32M | $-25M | $-32M | $-38M | $-5M | $-16M | $-25M | $-23M | $-20M | $-20M | $-19M | $-17M | $-15M | $-14M | |
| EPS (Basic) | $-0.76 | $-0.57 | $-1.76 | $-0.48 | $-0.86 | $-12.10 | $4.41 | $-5.16 | $-0.86 | $-0.83 | $-0.73 | $-0.71 | $-0.76 | $-0.67 | $-0.60 | $-0.56 | |
| EPS (Diluted) | $-0.76 | $-0.57 | $-1.76 | $-0.48 | $-0.86 | $-12.10 | $4.41 | $-5.16 | $-0.86 | $-0.83 | $-0.73 | $-0.71 | $-0.76 | $-0.67 | $-0.60 | $-0.56 | |
| Shares (Basic) | 61,050,775 | 57,777,165 | · | 39,584,489 | 28,431,158 | 3,155,500 | · | 3,155,500 | 28,756,043 | 27,795,827 | · | 27,640,542 | 25,166,505 | 24,777,847 | · | 24,454,786 | |
| Shares (Diluted) | 61,050,775 | 57,777,165 | · | 39,584,489 | 28,431,158 | 3,155,500 | · | 3,155,500 | 28,756,043 | 27,795,827 | · | 27,640,542 | 25,166,505 | 24,777,847 | · | 24,454,786 | |
| EBITDA | $-59M | $-43M | · | $-27M | $-28M | $-3M | · | $-17M | $-26M | $-25M | · | $-21M | $-20M | $-18M | · | $-14M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $107M | $55M | $88M | $50M | $221M | $44M | $34M | $31M | $31M | $9M | $23M | $32M | $61M | $27M | $22M | $22M | |
| Short-term Investments | $354M | $256M | $248M | $149M | · | $32M | $45M | $58M | $73M | $90M | $99M | $103M | $89M | $92M | $107M | $120M | |
| Prepaid Expense | $10M | $7M | $13M | $2M | $2M | $1M | $1M | $2M | $7M | $4M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Current Assets | $471M | $319M | $349M | $201M | $223M | $77M | $80M | $91M | $111M | $103M | $124M | $138M | $152M | $121M | $131M | $145M | |
| PP&E (Net) | $144.0K | $157.0K | $170.0K | $176.0K | $147.0K | $2.0K | $6.0K | $14.0K | $232.0K | $260.0K | $288.0K | $316.0K | $245.0K | $267.0K | $242.0K | $330.0K | |
| Other Non-current Assets | $69.0K | $69.0K | $69.0K | $174.0K | $60.0K | · | · | $81.0K | $81.0K | $3M | $2M | $2M | $2M | $3M | $3M | $1M | |
| Total Assets | $472M | $319M | $350M | $202M | $224M | $78M | $80M | $91M | $112M | $107M | $127M | $141M | $156M | $124M | $135M | $148M | |
| Accounts Payable | $7M | $4M | $2M | $1M | $8M | $69.0K | $224.0K | $908.0K | $4M | $3M | $2M | $4M | $6M | $5M | $3M | $5M | |
| Accrued Liabilities | $15M | $15M | $9M | $14M | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $32M | $22M | $17M | $22M | $22M | $2M | $4M | $10M | $17M | $16M | $18M | $15M | $13M | $11M | $8M | $8M | |
| Capital Leases | $628.0K | $679.0K | $724.0K | $747.0K | $792.0K | · | · | $81.0K | $206.0K | $329.0K | $255.0K | $358.0K | $476.0K | $591.0K | $705.0K | $800.0K | |
| Total Liabilities | $32M | $23M | $17M | $23M | $22M | $2M | $4M | $10M | $17M | $16M | $18M | $15M | $14M | $11M | $9M | $9M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $711M | $512M | $507M | $322M | $319M | $311M | $309M | $308M | $306M | $278M | $273M | $269M | $266M | $218M | $215M | $213M | |
| Retained Earnings | $-271M | $-215M | $-174M | $-142M | $-117M | $-236M | $-233M | $-228M | $-211M | $-187M | $-163M | $-143M | $-123M | $-104M | $-88M | $-73M | |
| AOCI | $-660.0K | $-342.0K | $129.0K | $29.0K | $-24.0K | $50.0K | $105.0K | $224.0K | $-83.0K | $-33.0K | $237.0K | $-195.0K | $-223.0K | $-201.0K | $-466.0K | $-771.0K | |
| Stockholders' Equity | $440M | $296M | $333M | $179M | $202M | $75M | $76M | $80M | $94M | $91M | $109M | $126M | $142M | $113M | $127M | $139M | |
| Liabilities + Equity | $472M | $319M | $350M | $202M | $224M | $78M | $80M | $91M | $112M | $107M | $127M | $141M | $156M | $124M | $135M | $148M | |
| Shares Outstanding | 63,556,065 | 49,345,967 | 49,316,287 | 32,626,730 | 32,626,730 | 28,985,019 | 28,985,019 | 28,867,711 | 28,854,750 | 27,898,761 | 27,762,703 | 27,653,187 | 27,601,098 | 24,816,940 | 24,722,974 | 24,506,390 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $7M | $11M | $4M | $4M | $2M | $3M | $27.0K | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Operating Cash Flow | $-44M | $-24M | $-34M | $-22M | $-37M | $-19M | $-11M | $-7M | $-20M | $-24M | $-15M | $-16M | $-15M | $-11M | $-15M | $-10M | |
| CapEx | · | · | $3.0K | $57.0K | · | · | · | · | · | · | $64.0K | $32.0K | $30.0K | $16.0K | $4.0K | $33.0K | |
| Investing Cash Flow | $-98M | $-8M | $-98M | $-149M | $-13M | $13M | $13M | $0 | $18M | $9M | $6M | $-13M | $4M | $15M | $14M | $5M | |
| Stock Issued | · | · | · | · | · | · | $307.0K | $0 | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $194M | $-795.0K | $170M | $0 | $191M | $-700.0K | $554.0K | $95M | $24M | $471.0K | $463.0K | $20.0K | $45M | $223.0K | $357.0K | $37.0K | |
| Net Change in Cash | $52M | $-33M | $38M | $-171M | $141M | $-19M | $3M | $88M | $22M | $-14M | $-9M | $-29M | $34M | $4M | $-22.0K | $-5M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-11M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -16.0% | -20.3% | · | -17.2% | -19.1% | -2.7% | · | -14.0% | -18.5% | -20.1% | · | -13.6% | -12.2% | -11.3% | · | -8.2% | |
| ROE | -17.4% | -21.7% | · | -19.4% | -21.7% | -3.0% | · | -15.8% | -21.0% | -22.7% | · | -14.8% | -13.0% | -12.0% | · | -8.5% | |
| ROIC | -13.4% | -14.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.9 | 14.3 | · | 9.0 | 10.3 | 32.0 | · | 8.8 | 6.5 | 6.7 | · | 9.3 | 11.5 | 11.3 | · | 18.8 | |
| Quick Ratio | 14.6 | 14.0 | · | 8.9 | 10.2 | 31.5 | · | 8.6 | 6.1 | 6.4 | · | 9.2 | 11.3 | 11.2 | · | 18.5 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.92 | $6.01 | · | $5.50 | $6.18 | $2.59 | · | $2.79 | $3.27 | $3.26 | · | $4.55 | $5.14 | $4.56 | · | $5.68 | |
| Cash Flow / Share | · | $-0.42 | · | · | · | $-0.08 | · | · | · | $-0.85 | · | · | · | $-0.46 | · | · | |
| Cash / Share | $1.69 | $1.12 | · | $1.54 | $6.77 | $1.53 | · | $1.08 | $1.08 | $0.33 | · | $1.16 | $2.21 | $1.07 | · | $0.91 | |
| EPS (TTM) | $-3.57 | $-3.67 | · | $-9.03 | $-13.71 | $-13.71 | · | $-7.58 | $-3.13 | $-3.03 | · | $-2.74 | $-2.59 | $-2.32 | · | $-1.57 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-153M | $-130M | · | $-101M | $-92M | $-85M | · | $-85M | $-88M | $-82M | · | $-70M | $-64M | $-57M | · | $-45M | |
| Market Cap | $1.41B | $693M | · | $282M | $326M | $2.55B | · | $2.11B | $1.68B | $28.87B | · | $13.13B | $16.57B | $17.52B | · | $14.22B | |
| P/E | -6.2 | -3.8 | · | -1.0 | -0.7 | -6.4 | · | -9.7 | -18.6 | -341.6 | · | -173.3 | -231.8 | -304.3 | · | -369.6 | |
| P/B | 3.2 | 2.3 | · | 1.6 | 1.6 | 33.9 | · | 26.2 | 17.8 | 317.6 | · | 104.5 | 116.7 | 154.9 | · | 102.2 | |
| P / Tangible Book | 3.2 | 2.3 | · | 1.6 | 1.6 | 33.9 | · | 26.2 | 17.8 | 317.6 | · | 104.5 | 116.7 | 154.9 | · | 102.2 | |
| P / Cash Flow | · | -28.8 | · | · | · | -1069.4 | · | · | · | -1219.7 | · | · | · | -1533.6 | · | · | |
| Earnings Yield | -16.1% | -26.1% | · | -104.6% | -137.2% | -15.6% | · | -10.4% | -5.4% | -0.29% | · | -0.58% | -0.43% | -0.33% | · | -0.27% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-127M | $-70M | $-76M | $-52M | $-23M |
| EPS Diluido | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 21.1 | 20.9 | 7.0 | 16.9 | 68.4 |
| Ratio Rápido | 20.3 | 20.5 | 6.9 | 16.6 | 65.6 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-95M | · | $-57M | $-39M | $-28M |
Propietarios institucionales (13F) 159 declarantes · $1.6B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
159
Valor en tenencia
$1.6B
Nuevas posiciones
52
Posiciones cerradas
16
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 52 (+18 vs trimestre anterior) | 16 (+5 vs trimestre anterior) | 61 (+24 vs trimestre anterior) | 24 (-8 vs trimestre anterior) | +16.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $202 799 207 | 9 126 877 | 13,07% | Acciones |
| Fairmount Funds Management LLC | $101 178 637 | 4 553 494 | 6,52% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $81 571 464 | 3 671 083 | 5,26% | Acciones |
| Venrock Adviser, LLC | $71 556 488 | 3 220 364 | 4,61% | Acciones |
| Bellevue Group AG | $67 948 671 | 3 057 996 | 4,38% | Acciones |
| Paradigm Biocapital Advisors LP | $63 491 539 | 2 857 405 | 4,09% | Acciones |
| BlackRock, Inc. | $62 248 241 | 2 801 451 | 4,01% | Acciones |
| FRANKLIN RESOURCES INC | $62 040 028 | 2 792 080 | 4,00% | Acciones |
| STATE STREET CORP | $51 890 033 | 2 335 285 | 3,34% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $49 878 856 | 2 244 773 | 3,21% | Acciones |
| JANUS HENDERSON GROUP PLC | $43 557 008 | 3 105 669 | 2,81% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $42 458 243 | 1 910 812 | 2,74% | Acciones |
| Polar Capital Holdings Plc | $41 039 940 | 1 846 982 | 2,64% | Acciones |
| Avidity Partners Management LP | $37 789 732 | 1 700 708 | 2,43% | Acciones |
| Remedium Capital Partners, LLC | $35 057 605 | 1 577 750 | 2,26% | Acciones |
| Soleus Capital Management, L.P. | $34 456 332 | 1 550 690 | 2,22% | Acciones |
| JPMORGAN CHASE & CO | $32 613 997 | 1 475 079 | 2,10% | Acciones |
| VANGUARD GROUP INC | $32 337 685 | 2 095 767 | 2,08% | Acciones |
| BAKER BROS. ADVISORS LP | $27 340 066 | 1 230 426 | 1,76% | Acciones |
| Logos Global Management LP | $24 997 500 | 1 125 000 | 1,61% | Acciones |
| Versant Venture Management, LLC | $22 037 418 | 991 783 | 1,42% | Acciones |
| ACORN CAPITAL ADVISORS, LLC | $21 925 807 | 986 760 | 1,41% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $21 896 658 | 985 178 | 1,41% | Acciones |
| CITADEL ADVISORS LLC | $20 651 423 | 929 407 | 1,33% | Acciones |
| Foresite Capital Management VI LLC | $19 701 741 | 886 667 | 1,27% | Acciones |
| Balyasny Asset Management L.P. | $19 525 292 | 878 726 | 1,26% | Acciones |
| Affinity Asset Advisors, LLC | $18 672 577 | 840 350 | 1,20% | Acciones |
| SAMSARA BIOCAPITAL, LLC | $16 359 186 | 736 237 | 1,05% | Acciones |
| GOLDMAN SACHS GROUP INC | $16 336 678 | 735 224 | 1,05% | Acciones |
| Pictet Asset Management Holding SA | $16 304 325 | 733 768 | 1,05% | Acciones |
| Aberdeen Group plc | $13 801 020 | 621 108 | 0,89% | Acciones |
| MARSHALL WACE, LLP | $13 015 609 | 585 761 | 0,84% | Acciones |
| BANK OF AMERICA CORP /DE/ | $10 820 140 | 486 955 | 0,70% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10 255 152 | 461 528 | 0,66% | Acciones |
| Blackstone Inc. | $9 672 810 | 435 320 | 0,62% | Acciones |
| Ikarian Capital, LLC | $9 495 694 | 427 349 | 0,61% | Acciones |
| Walleye Capital LLC | $8 116 344 | 365 272 | 0,52% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $6 989 257 | 314 548 | 0,45% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $6 774 145 | 304 867 | 0,44% | Acciones |
| NORTHERN TRUST CORP | $6 556 700 | 295 081 | 0,42% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $4 825 229 | 217 157 | 0,31% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $4 431 312 | 199 429 | 0,29% | Acciones |
| Jump Financial, LLC | $3 838 439 | 172 747 | 0,25% | Acciones |
| Point72 Asset Management, L.P. | $3 715 273 | 167 204 | 0,24% | Acciones |
| Russell Investments Group, Ltd. | $3 623 746 | 163 084 | 0,23% | Acciones |
| Opaleye Management Inc. | $3 221 900 | 145 000 | 0,21% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $3 114 989 | 140 886 | 0,20% | Acciones |
| UBS Group AG | $2 834 761 | 127 577 | 0,18% | Acciones |
| MORGAN STANLEY | $2 766 679 | 124 513 | 0,18% | Acciones |
| Quantinno Capital Management LP | $2 548 990 | 114 716 | 0,16% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Fairmount Healthcare Co-Invest IV L.P., Peter Evan Harwin, Tomas Kiselak ×3 presentaciones | 9 de junio de 2026 | 19,99% | Enmienda | · | SEC |
| Sofinnova Venture Partners X, L.P. ("SVP X"), Sofinnova Management X, L.P. ("SM X LP"), Sofinnova Management X-A, L.L.C. ("SM X LLC"), Dr. James I. Healy ("Healy"), Dr. Maha Katabi ("Katabi") | 5 de marzo de 2026 | 0,30% | Enmienda | Inversión pasiva | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 presentaciones | 30 de abril de 2025 | 4,10% | Enmienda | · | SEC |
| Atlas Venture Fund XII, L.P., Atlas Venture Associates XII, L.P., Atlas Venture Associates XII, LLC ×5 presentaciones | 30 de abril de 2025 | 0,20% | Enmienda | M&A / venta | SEC |
| Sofinnova Venture Partners X, L.P. (“SVP X”), Sofinnova Management X, L.P. (“SM X LP”), Sofinnova Management X-A, L.L.C. (“SM X LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) ×3 presentaciones | 20 de febrero de 2024 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 24 insiders · 11 directivos · 14 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Tom Frohlich | Chief Executive Officer | 12 de febrero de 2026 A | 86 331 | 0 | 0 | $0 |
| Timothy P Noyes | CHIEF EXECUTIVE OFFICER | 16 de mayo de 2024 M | 0 | 0 | 0 | $0 |
| Bradford D. Dahms | Chief Financial Officer | 12 de febrero de 2026 A | 37 813 | 0 | 0 | $0 |
| George A Eldridge | Officer Title: Chief Financial Officer and Treasurer | 14 de junio de 2024 M | 5 022 | 0 | 0 | $0 |
| Benjamin T Dake | Officer Title: President, Chief Operating Officer and Secretary | 1 de agosto de 2024 M | 14 252 | 0 | 0 | $0 |
| Elizabeth Balta | Chief Legal Officer and Corporate Secretary | 12 de febrero de 2026 A | 28 125 | 0 | 0 | $0 |
| Andrew James King | Chief Scientific Officer & Head of Research and Development | 12 de febrero de 2026 A | 386 113 | 0 | 0 | $0 |
| Marinus Verwijs | CHIEF TECHNICAL OFFICER | 14 de junio de 2024 M | 0 | 0 | 0 | $0 |
| Hunter Gillies | CHIEF MEDICAL OFFICER | 13 de junio de 2024 M | 5 602 | 0 | 0 | $0 |
| Ralph Niven | CHIEF SCIENTIFIC OFFICER | 5 de febrero de 2024 M | 1 609 | 0 | 0 | $0 |
| Timothy Pigot | CHIEF COMMERCIAL OFFICER | 22 de enero de 2024 A | · | 0 | 0 | $0 |
| Mark Eisner | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Christopher W. Cain | Consejero | 9 de junio de 2026 A | · | 0 | 0 | $0 |
| Lawrence Otto Klein | Consejero | 9 de junio de 2026 A | · | 0 | 0 | $0 |
| Erin Lavelle | Consejero | 9 de junio de 2026 A | · | 0 | 0 | $0 |
| Eric Dobmeier | Consejero | 9 de junio de 2026 A | · | 0 | 0 | $0 |
| David S. Grayzel | Consejero | 5 de junio de 2024 A | 14 502 | 0 | 0 | $0 |
| Dr. Maha Katabi | Consejero | 5 de junio de 2024 A | 3 758 686 | 0 | 0 | $0 |
| Joshua Resnick | Consejero | 5 de junio de 2024 A | · | 0 | 0 | $0 |
| Habib J Dable | Consejero | 5 de junio de 2024 A | · | 0 | 0 | $0 |
| Allison Dorval | Consejero | 5 de junio de 2024 A | · | 0 | 0 | $0 |
| Mark T Iwicki | Consejero | 5 de junio de 2024 A | · | 0 | 0 | $0 |
| Donald J Santel | Consejero | 5 de junio de 2024 A | · | 0 | 0 | $0 |
| Atlas Venture Fund XII, L.P. | Propietario del 10% | 15 de julio de 2022 J | 2 327 909 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 19 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,86% | 20 261 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,21% | 52 113 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,15% | 110 135 SH | 11 de septiembre de 2026 | Diario |
| FFSM · FIDELITY COVINGTON TRUST | 0,12% | 93 021 NS | 31 de julio de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 111 509 SH | 19 de agosto de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,06% | 712 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,04% | 305 709 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 34 886 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,02% | 836 516 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 187 416 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 19 767 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 489 225 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 124 984 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 2 568 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 71 131 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 15 055 SH | 9 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 699 343 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 733 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 2 353 SH | 11 de septiembre de 2026 | Diario |
JBIO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 17 analistas
COMPRA
Objetivo mediano
$47.00
+232,9%
8 47,1%
Compra fuerte
8 47,1%
Compra
1 5,9%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
8 analistas · 2026-10-02Objetivo medio $50.12 +255,0%
← Por Debajo de Todos los Objetivos
Precio Actual $14.12
Mín$40.00
Media$50.12
Máx$77.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| OBX | · | · | · | · | · | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026